Corium International Organization
Corium International engages in the development of advanced transdermal drug delivery technologies and products.
Investor Type:
Healthcare Company
Technology:
Immunotherapy
Investment Stage:
N/A
Estimated Revenue:
$10M to $50M
Founded Date:
1995
Industry:
PharmTech
Employee Number:
501-1000
Funding Status:
M&A
Number Of Exists:
N/A
Headquarters:
Menlo Park, California, United States